Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia

N Engl J Med. 2021 Aug 26;385(9):857-859. doi: 10.1056/NEJMc2109465. Epub 2021 Jul 7.

Affiliations

¹ University Health Network, Toronto, ON, Canada christopher.patriquin@uhn.ca.
² CHU de Québec-Université Laval, Quebec, QC, Canada.
³ University Health Network, Toronto, ON, Canada.
⁴ Ottawa Hospital Research Institute, Ottawa, ON, Canada.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anticoagulants / therapeutic use*
COVID-19 Vaccines / adverse effects*
ChAdOx1 nCoV-19
Combined Modality Therapy
Female
Fibrin Fibrinogen Degradation Products / analysis
Glucocorticoids / therapeutic use
Humans
Immunoglobulins, Intravenous / therapeutic use
Methylprednisolone / therapeutic use
Middle Aged
Plasma Exchange*
Platelet Count
Prednisone / therapeutic use
Purpura, Thrombocytopenic, Idiopathic / etiology
Purpura, Thrombocytopenic, Idiopathic / therapy*
Thrombosis / etiology
Thrombosis / therapy*

Substances

Anticoagulants
COVID-19 Vaccines
Fibrin Fibrinogen Degradation Products
Glucocorticoids
Immunoglobulins, Intravenous
fibrin fragment D
ChAdOx1 nCoV-19
Prednisone
Methylprednisolone